Table 2.
Lipid-lowering effect | Lipid-lowering effect | ||
---|---|---|---|
Aorta | Coronary arteries | ||
Cholesterol synthesis inhibitors | |||
Statins | O | X, O | O |
Squalene synthesis inhibitor | O | O | O |
Anion exchanger | O | O | |
Statins + Anion exchanger | O | O | O |
MTP inhibitor | O | ||
ACAT inhibitor | X, O | X, O | X, O |
Antioxidants | |||
Probucol | O | O | |
Vitamin E | X | X, O | |
Colony stimulating factor | |||
MCSF | X, O | O | |
GMCSF | X, O | O | |
Apo E | X, O | O | |
Fibrate | X | ||
Fish oils, ommega-3 fatty acids | X, O | X, O | |
Thiazolidinedione | X | Δ | Δ |
Thiazolidinedione + statin | O | O | O |
Antihypertensive | |||
ACE inhibitor | X | O | |
AT-II receptor antagonists | X | O | |
Calcium antagonists | X | X | |
Beta-blockers | X | X | |
Gene therapy | O |
O: effective; Δ: partly effective; X: no effect.
Modified from Shiomi and Ito [8].